Zydus receives USFDA final approval for Bisoprolol Fumarate and Hydrochlorothiazide tablets | Tech Reddy
[ad_1] Zydus Lifesciences has received approval from the United States Food and Drug Administration (USFDA) for Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, 10 mg/6.25 mg (USRLD : Ziac tablets) received final marketing approval. The combination of bisoprolol fumarate and hydrochlorothiazide is indicated for the treatment of high blood pressure … Read more